Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remezolam vs propofol anesthesia for postoperative inflammatory response after ureteroscopic holmium laser lithotripsy
ChiCTR2300070006Phase 4Completed
- Sponsor
- The Affiliated Hospital of Guangdong Medical University
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of remimazolam in ureterolithiasis (2 arms), sponsored by The Affiliated Hospital of Guangdong Medical University. Primary endpoint: Procalcitonin (PCT). Started Apr 2023; status: completed.
02
Drugs
remimazolam
03
Conditions
ureterolithiasis
Beyond the preview
Go deeper on ChiCTR2300070006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300070006.